News Briefing channel feed – Endpoints News

News Briefing channel feed

Vera redraws the terms of up to $500M credit facility; Trevi aims to raise $100M

Last month

Sanofi pays out two STAT6 milestones; Theravance sells more Trelegy royalties

Last month

Roche’s 96-week data for multiple sclerosis drug; ZymeWorks claims $20M milestone

Last month

Taysha’s pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff

Last month

Veru’s obesity drug roughly as safe as Wegovy; Keros’ board fight

Last month

ITM reveals up to $262M debt financing; Caris Life Sciences to go public

Last month

GLP-1s may cut cancer risk; Gyre’s stock falls after hep B data and offering

Last month

Moderna pulls application for Covid-flu shot; Another IPO in Hong Kong

Last month

SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff

Last month

Ionis details late-stage data for heart drug; Armata’s promising staph infection therapy

Last month

FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval

Last month

Enliven stops work on solid tumor drug; Pulmatrix to divest assets

Last month

SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M

Last month

Axsome's $570M loan with Blackstone; Altimmune makes its own credit deal

Last month

FDA clears in vivo blood stem cell editing trial; Abeona's $155M PRV sale

Last month

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

2 months ago

ALX Oncology won’t seek approval for CD47 drug in gastric cancer; Korro Bio’s layoffs

2 months ago

European regulators to review Valneva shot; Jazz's stock dips on subpar first-quarter revenue

2 months ago

Lilly to pay up to $415M in ALS deal; Actuate’s mid-stage pancreatic cancer data

2 months ago

Unity lays off 'all' workers; Novo to get FDA decision on oral Wegovy this year

2 months ago

Kura gets $45M milestone payment from Kyowa Kirin; Pliant’s restructuring

2 months ago

Arvinas ends plans for two Phase 3 breast cancer trials; Phathom makes cuts

2 months ago

Immunic’s stock falls on multiple sclerosis data; Entrada’s layoffs

2 months ago

AbbVie’s Rinvoq is approved in giant cell arteritis; Relmada shares bladder cancer data

2 months ago

First page Previous page 123 4 5 Next page Last page